157 related articles for article (PubMed ID: 25497874)
41. Value of DCE-MRI for staging and response evaluation in rectal cancer: A systematic review.
Dijkhoff RAP; Beets-Tan RGH; Lambregts DMJ; Beets GL; Maas M
Eur J Radiol; 2017 Oct; 95():155-168. PubMed ID: 28987662
[TBL] [Abstract][Full Text] [Related]
42. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
[TBL] [Abstract][Full Text] [Related]
43. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
[TBL] [Abstract][Full Text] [Related]
44. Can Endorectal Ultrasound, MRI, and Mucosa Integrity Accurately Predict the Complete Response for Mid-Low Rectal Cancer After Preoperative Chemoradiation? A Prospective Observational Study from a Single Medical Center.
Liu S; Zhong GX; Zhou WX; Xue HD; Pan WD; Xu L; Lu JY; Wu B; Lin GL; Qiu HZ; Xiao Y
Dis Colon Rectum; 2018 Aug; 61(8):903-910. PubMed ID: 29944579
[TBL] [Abstract][Full Text] [Related]
45. DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer.
Heethuis SE; Goense L; van Rossum PSN; Borggreve AS; Mook S; Voncken FEM; Bartels-Rutten A; Aleman BMP; van Hillegersberg R; Ruurda JP; Meijer GJ; Lagendijk JJW; van Lier ALHMW
Acta Oncol; 2018 Sep; 57(9):1201-1208. PubMed ID: 29781342
[TBL] [Abstract][Full Text] [Related]
46. Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI.
Nie K; Shi L; Chen Q; Hu X; Jabbour SK; Yue N; Niu T; Sun X
Clin Cancer Res; 2016 Nov; 22(21):5256-5264. PubMed ID: 27185368
[TBL] [Abstract][Full Text] [Related]
47. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.
Jung SH; Heo SH; Kim JW; Jeong YY; Shin SS; Soung MG; Kim HR; Kang HK
J Magn Reson Imaging; 2012 Jan; 35(1):110-6. PubMed ID: 21989997
[TBL] [Abstract][Full Text] [Related]
48. Study protocol: multi-parametric magnetic resonance imaging for therapeutic response prediction in rectal cancer.
Pham TT; Liney G; Wong K; Rai R; Lee M; Moses D; Henderson C; Lin M; Shin JS; Barton MB
BMC Cancer; 2017 Jul; 17(1):465. PubMed ID: 28676107
[TBL] [Abstract][Full Text] [Related]
49. Combined use of 18F-FDG PET/CT, DW-MRI, and DCE-MRI in treatment response for preoperative chemoradiation therapy in locally invasive rectal cancers.
Gu J; Khong PL; Wang S; Law W; Chan T; Shek TW; Liu R; Zhang J
Clin Nucl Med; 2013 May; 38(5):e226-9. PubMed ID: 23235482
[TBL] [Abstract][Full Text] [Related]
50. [The value of MRI with CUBE sequence in early evaluation of the efficacy of neoadjuvant therapy for locally advanced rectal cancer].
Wang X; Cao W; Liu D; Li F; Li W; Kang L; Deng Y; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):73-78. PubMed ID: 29354903
[TBL] [Abstract][Full Text] [Related]
51. Correlation between quantitative and semiquantitative parameters in DCE-MRI with a blood pool agent in rectal cancer: can semiquantitative parameters be used as a surrogate for quantitative parameters?
Dijkhoff RAP; Maas M; Martens MH; Papanikolaou N; Lambregts DMJ; Beets GL; Beets-Tan RGH
Abdom Radiol (NY); 2017 May; 42(5):1342-1349. PubMed ID: 28050622
[TBL] [Abstract][Full Text] [Related]
52. MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report.
Petrillo M; Fusco R; Catalano O; Sansone M; Avallone A; Delrio P; Pecori B; Tatangelo F; Petrillo A
Biomed Res Int; 2015; 2015():514740. PubMed ID: 26413528
[TBL] [Abstract][Full Text] [Related]
53. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.
Yoon HJ; Kim SK; Kim TS; Im HJ; Lee ES; Kim HC; Park JW; Chang HJ; Choi HS; Kim DY; Oh JH
Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038
[TBL] [Abstract][Full Text] [Related]
54. Usefulness of perfusion CT to assess response to neoadjuvant combined chemoradiotherapy in patients with locally advanced rectal cancer.
Curvo-Semedo L; Portilha MA; Ruivo C; Borrego M; Leite JS; Caseiro-Alves F
Acad Radiol; 2012 Feb; 19(2):203-13. PubMed ID: 22130088
[TBL] [Abstract][Full Text] [Related]
55. [Value of functional magnetic resonance imaging in predicting outcomes of neoadjuvant chemoradiotherapy in rectal cancer].
Yu Y; Yue J; Yu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):491-494. PubMed ID: 28534322
[TBL] [Abstract][Full Text] [Related]
56. Sex Differences and Tumor Blood Flow from Dynamic Susceptibility Contrast MRI Are Associated with Treatment Response after Chemoradiation and Long-term Survival in Rectal Cancer.
Bakke KM; Meltzer S; Grøvik E; Negård A; Holmedal SH; Gjesdal KI; Bjørnerud A; Ree AH; Redalen KR
Radiology; 2020 Nov; 297(2):352-360. PubMed ID: 32870132
[TBL] [Abstract][Full Text] [Related]
57. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer.
Lim JS; Kim D; Baek SE; Myoung S; Choi J; Shin SJ; Kim MJ; Kim NK; Suh J; Kim KW; Keum KC
Eur Radiol; 2012 Aug; 22(8):1693-700. PubMed ID: 22427184
[TBL] [Abstract][Full Text] [Related]
58. MR imaging perfusion and diffusion analysis to assess preoperative Short Course Radiotherapy response in locally advanced rectal cancer: Standardized Index of Shape by DCE-MRI and intravoxel incoherent motion-derived parameters by DW-MRI.
Petrillo A; Fusco R; Granata V; Setola SV; Sansone M; Rega D; Delrio P; Bianco F; Romano GM; Tatangelo F; Avallone A; Pecori B
Med Oncol; 2017 Nov; 34(12):198. PubMed ID: 29151142
[TBL] [Abstract][Full Text] [Related]
59. Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer.
Elmi A; Hedgire SS; Covarrubias D; Abtahi SM; Hahn PF; Harisinghani M
Clin Radiol; 2013 Oct; 68(10):e524-31. PubMed ID: 23830776
[TBL] [Abstract][Full Text] [Related]
60. Pretreatment evaluation of microcirculation by dynamic contrast-enhanced magnetic resonance imaging predicts survival in primary rectal cancer patients.
DeVries AF; Piringer G; Kremser C; Judmaier W; Saely CH; Lukas P; Öfner D
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1161-7. PubMed ID: 25260490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
